Exhibit 10.1


 


Separation
Agreement and Release


 


This Separation Agreement and Release (the “Agreement”)
sets forth the terms of your separation from employment with CorMedix Inc. (the “Company”). If you understand and agree with
these terms, please sign in the space provided below. If you and the Company sign below, this will be a legally binding document representing
the entire agreement between you and the Company regarding the subjects it covers. We will refer to this document as the “Agreement.”


 


Termination Date. You and the Company have mutually agreed that
your last day of work with the Company will be October 4, 2021 (“Termination Date”). You hereby acknowledge that all officer,
director and other positions you may have held with the Company and its affiliates terminate effective as of the Termination Date without
further action by either party hereto.


 


Consideration. In
exchange for the promises contained in this Agreement and in accordance with the terms of the Employment Agreement dated September 26,
2019 between you and the Company (the “Employment Agreement”), the Company will pay or provide you the following if you sign
and do not revoke this Agreement:


 


		●	Base salary as of the date of this Agreement ($35,416.67 per month) for a
period of twelve (12) months following the Termination Date, which shall be payable in accordance with the Company’s payroll practices
and procedures beginning no later than the 30th day following the Termination Date. The first payment will include unpaid installments
for the period from the Termination Date to the first payment date. 



 


		●	Lump sum payment of $70,833.34, which represents base salary for 60 days
as pay in lieu of notice. The payment will be made no later than the 30th day following the Termination Date.



 


		●	Prorated annual bonus for 2021 (if any) based upon and subject to the actual
achievement of the objectives established by the Board of Directors of the Company (“Board”) for the 2021 year, which shall
be paid at the date on which the annual bonus would have been paid had you continued in employment; the prorated bonus shall be calculated
by multiplying the annual bonus amount determined by the Board by a fraction, the numerator of which is the number of days preceding the
Termination Date in 2021 and the denominator of which is 365. 



 


		●	If you timely elect continued health insurance coverage under COBRA, monthly
payment of a portion of your COBRA premium for a period of twelve (12) months following the Termination Date or until you became eligible
for group health insurance coverage under another employer’s plan, whichever occurs first. Such portion shall be equal to the monthly
amount paid by the Company for active coverage as of the Termination Date for you and your eligible dependents. The COBRA payments shall
begin on the date on which the salary continuation payments commence.



 


		●	All time-based stock options that are scheduled to vest on or before the
first anniversary of the Termination Date (i.e., October 4, 2022) shall be accelerated and deemed to have vested as of the Termination
Date. Your performance-based stock options which are not vested as of the Termination Date shall not accelerate and shall be forfeited
as of the Termination Date. You shall have met the requirements for retirement eligibility as of the Termination Date for purposes of
your vested stock options, so all of your vested stock options may be exercised through the three-year anniversary of the Termination
Date (i.e., October 4, 2024) (but not beyond the end of the option term) in accordance with the grant agreements. Attached as Exhibit
A is a list of your vested options.



 


Payments Without Regard to this Agreement. Whether or not you
sign this Agreement, you shall receive (i) payment of any accrued but unpaid salary and paid time off through the Termination Date, (ii)
payment of any reimbursable business expenses incurred before the Termination Date subject to the Company’s policies, and (iii)
payment of any amounts due under any benefit plan or program in accordance with its terms through the Termination Date.


 






     


     


    

 


Release of Claims. In
exchange for the payments and benefits described in the “Consideration” section, you hereby waive all claims available under
federal, state or local law against the Company, its parent, partners and affiliates, and its and their respective directors, officers,
employees, agents, insurers and reinsurers, and employee benefit plans (and the trustees, administrators, fiduciaries, insurers and reinsurers
of such plans) past, present, and future, their heirs, executors, administrators, representatives, successors and assigns (collectively,
the “Releasees”), arising out of your employment with the Company or the termination of that employment, including but not
limited to all claims arising under the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Americans
with Disabilities Act, the Civil Rights Act of 1991, the Employee Retirement Income Security Act, the Equal Pay Act, the Genetic Information
Non-discrimination Act, the Family and Medical Leave Act, Section 1981 of U.S.C, Title VII of the Civil Rights Act, the New Jersey Law
Against Discrimination, New Jersey Equal Pay Act, New Jersey Civil Rights Law, New Jersey Security and Financial Empowerment Act, New
Jersey Conscientious Employee Protection Act, New Jersey Family Leave Act, New Jersey Earned Sick Leave Law, New Jersey Wage Payment Law,
New Jersey Wage and Hour Law, New Jersey WARN Laws, retaliation provisions of New Jersey Workers’ Compensation Law, as well as wrongful
termination claims, breach of contract claims, discrimination claims, harassment claims, retaliation claims, whistleblower claims (to
the fullest extent they may be released under applicable law), defamation or other tort claims, and claims for attorneys’ fees and
costs. You are not waiving your right to (i) vested benefits under the written terms of the Company 401(k) plan, (ii) claims for unemployment
or workers’ compensation benefits, (iii) any medical claim or any judgment or monetary awards or settlements that may arise related
to medical benefits under the group health plan sponsored by the Company, (iv) claims arising after the date on which you sign this Agreement,
(v) claims that are not otherwise waivable under applicable law, (vii) claims to indemnification under Section 11 of the Employment Agreement
or under the Indemnification Agreement between you and the Company dated as of June 25, 2017, or (viii) claims to enforce this Agreement.
You acknowledge that you have not made any claims or allegations related to sexual harassment or sexual abuse and none of the payments
set forth in this Agreement are related to sexual harassment or sexual abuse.


 


Legal Fees. The Company will
reimburse you for up to $20,000 of reasonable legal fees incurred in the review and negotiation of this Agreement.


 


Medicare Disclaimer. You
represent that you are not a Medicare Beneficiary as of the time you enter into this Agreement.


 


Limit on Disclosures. You shall not disclose or cause to be
disclosed the terms of this Agreement to any person (other than your spouse or domestic/civil union partner, attorney and tax advisor),
except pursuant to a lawful subpoena, as set forth in the Reports to Government Entities section below, or as otherwise permitted by law.
This provision is not intended to restrict your legal right to discuss the terms and conditions of your employment.


 


Provisions
of Employment Agreement Remaining In Full Force and Effect. You agree to comply with the confidentiality, inventions, non-competition,
non-solicitation and non-disparagement provisions of the Employment Agreement, which shall remain in effect according to their terms;
provided that the non-solicitation covenant in Section 6(c)(i) of the Employment Agreement (relating to non-solicitation of employees,
consultants and independent contractors) shall extend for 18 months after the Termination Date, instead of one year. All payments and
benefits under the “Consideration” section of this Agreement shall cease if you breach any of these provisions of the Employment
Agreement, and you shall be required to repay to the Company any payments or benefits previously
paid under this Agreement. If any stock options that vest as described
in this Agreement have been exercised, you shall be required to pay to the Company an amount equal to the fair market value of the stock
subject to such option on the date of exercise, less the exercise price paid pursuant to such exercise. You may share the confidentiality,
inventions, non-competition, non-solicitation and non-disparagement provisions of the Employment Agreement, as modified by this Agreement,
with any future employer or other entity for which you will provide services.


 


Cooperation. You agree to cooperate fully and in a timely manner
with the Company and its counsel with respect to any matter (including any litigation, investigation or governmental proceeding) which
relates to your employment with the Company, to provide consulting services as needed to assist in the transition to a new Chief Executive
Officer, and otherwise to continue to be available to advise and consult as requested by the Company with respect to matters relating
to the period during which you served as Chief Executive Officer. This cooperation may include answering questions relating to the transition
of your duties, appearing from time-to-time for conferences and interviews, including participating in calls initiated by the Board or
the then-Chief Executive Officer with employees and other key stakeholders relating to the transition of your responsibilities, and providing
the officers of the Company and its counsel with the full benefit of your knowledge with respect to any such matter. Subject to the Company’s
prior approval, the Company will reimburse you for reasonable out-of-pocket costs and expenses such as travel expenses, with respect to
such cooperation and will endeavor to set meeting times that are mutually agreeable.


 






    2


     


    

 


You further agree that any statements to employees, vendors, shareholders,
other constituents, or others regarding your termination from employment shall be consistent with any statements made by the Company and
shall be subject to the prior approval of the Board. The Board will provide you with the talking points that the Board and the Company
will use to communicate your separation from the Company.


 


In the event that you are made or threatened to be made a party to,
or are otherwise involved in, any action, suit or proceeding by reason of your service with the Company, you agree to provide the Chair
of the Board with prompt written notice of such matter. In the event that you seek indemnification with respect to legal fees relating
to any such matter under the Company’s bylaws, any directors and officers insurance, or otherwise, the Company shall have the right
to approve any counsel with respect to such matter in advance of any legal fees being incurred. The provisions of this paragraph do not
expand any provisions of the bylaws or any directors and officers insurance with respect to indemnification.


 


Reports to Government Entities. Nothing in this Agreement, including
the Limit on Disclosures or Release of Claims sections, restricts or prohibits you from initiating communications directly with, responding
to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation,
including alleged criminal conduct or sexual harassment, to, or from filing any type of claim, charge or complaint, or assisting with
an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity
Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission,
the Congress, and any agency Inspector General (collectively, the “Regulators”), or from making other disclosures that are
protected under the whistleblower provisions of state or federal law or regulation. However, to the maximum extent permitted by law, you
agree and understand that you are waiving your right to receive any individual monetary relief from the Releasees resulting from such
claims or conduct, regardless of whether you or another party has filed them, and in the event you obtain such monetary relief, the Releasees
will be entitled to seek an offset for the payments made pursuant to this Agreement. This Agreement does not limit your right to receive
an award from any Regulator that provides awards for providing information relating to a potential violation of law. You do not need the
prior authorization of the Company to engage in conduct protected by this paragraph, and you do not need to notify the Company that you
have engaged in such conduct. To the extent permitted by law, upon receipt of any subpoena, court order, or other legal process compelling
the disclosure of any confidential information or trade secrets of the Company, you agree to give prompt written notice to the Company
so as to permit the Company to protect its interests in confidentiality to the fullest extent possible.


 


Please take notice that federal law provides criminal and civil immunity
to federal and state claims for trade secret misappropriation to individuals who disclose a trade secret to their attorney, a court, or
a government official in certain, confidential circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related
to the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a
suspected violation of the law.


 


Non-Admission of Liability.  Nothing
in this Agreement is an admission of any wrongdoing, liability or unlawful activity by you or by the Company.


 


No Other Amounts Due. You
acknowledge that the Company has paid you all wages, salaries, bonuses, benefits and other amounts earned and accrued, less applicable
deductions, and that the Company has no obligation to pay any additional amounts other than the payments described in the “Consideration”
section of this Agreement.


 


Acknowledgement of Voluntariness and Time to Review.  You acknowledge
that:


 


		●	you read this Agreement and you understand it;



 


		●	you are signing this Agreement voluntarily in order to release your claims
against the Company in exchange for payment that is greater than you would otherwise have received;



 


		●	you are signing this Agreement after the date of your separation from the
Company and you were offered at least 21 days to consider your choice to sign this Agreement;



 


		●	the Company advises you to consult with an attorney about this Agreement;



 


		●	you know that you can revoke this Agreement within 7 days of signing it and
that the Agreement does not become effective until that 7-day period has passed (“Effective Date”). To revoke, provide written
notice of revocation to Phoebe Mounts at the Company, at pmounts@cormedix.com; and



 


		●	you agree that changes to this Agreement before its execution, whether material
or immaterial, do not restart your time to review the Agreement.



 






    3


     


    

 


Return of Records and Equipment. You agree that you have returned
(or within seven business days following the Termination Date, will return) all Company property, including but not limited to the Company
provided laptop, keys, ID card, cell phone, PDA, and Company documents and information (either hard copy or electronic) other than records
related solely to your own compensation or benefits. Promptly following the Termination Date, the Company will provide you with a pre-paid
box and mailing instructions for returning the Company property. You may keep your Company provided laptop and printer after the Company
has removed all Company information from such devices.


 


Conditional
Payments. If, after the date on which the Company signs this Agreement, the Board discovers information or conduct by you that would
constitute grounds for a termination for “Cause” (as that term is defined in your Employment Agreement) and that was not known
to the Board prior to the date on which the Company signs this Agreement, the Board may determine that all payments and benefits under
the “Consideration” section of this Agreement shall cease, and you shall be
required to repay to the Company any payments or benefits previously paid under such section. If
any stock options that vest as described in this Agreement have been exercised, you shall be required to pay to the Company an amount
equal to the fair market value of the stock subject to such option on the date of exercise, less the exercise price paid pursuant to such
exercise.


 


Tax Withholding. All payments under this Agreement shall be
made subject to applicable tax withholding.


 


Section 409A. This Agreement is intended to comply with section
409A of the Internal Revenue Code, or an exemption, and the provisions of this section shall apply notwithstanding any provisions of this
Agreement to the contrary. Payments and benefits under this Agreement are intended to be exempt from section 409A of the Code under the
“short-term deferral” exception, to the maximum extent applicable, and then under the “separation pay” exception,
to the maximum extent applicable. All payments to be made upon a termination of employment under this Agreement may only be made upon
a “separation from service” under section 409A of the Code. For purposes of section 409A of the Code, each payment shall be
treated as a separate payment. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided
under this Agreement comply with section 409A of the Code and in no event shall the Company be liable for any taxes, penalties, interest,
or other expenses that may be incurred by you on account of non-compliance with section 409A of the Code.


 


Entire Agreement. This Agreement sets forth the entire agreement
of the parties hereto and supersedes any and all prior agreements and understandings regarding all of the subjects covered by this Agreement.
This Agreement may be changed only by a written document signed by you and an authorized representative of the Company.


 


Severability. In the event a court, arbitrator or other entity
with jurisdiction determines that any portion of this Agreement (other than the general release section) is invalid or unenforceable,
the remaining portions of the Agreement shall remain in full force and effect.


 


Governing Law. This Agreement shall be governed by the laws
of New Jersey without reference to that jurisdiction’s choice of law rules.


 


The Company hereby advises you to consult with an attorney prior to
signing this Agreement. You acknowledge that you have had a reasonable amount of time to consider the terms of this Agreement and you
sign it with the intent to be legally bound.


 


[Signature Page Follows]


 









    4


     


    

 


	CORMEDIX INC.	 
	 	 
	/s/ Myron Kaplan  	 
	Date:	October 1, 2021	 




 


	KHOSO BALUCH	 
	 	 
	/s/ Khoso Baluch  	 
	Date:	October 1, 2021	 




 










     


     


    

 


Exhibit A


 


Vested Stock Options 


 


	Grant Date	 	Number of Vested Shares1	 
	9/30/2016	 	 	250,000	 
	9/30/2016	 	 	60,000	 
	1/10/2019	 	 	21,000	 
	1/10/2019	 	 	4,038	 
	1/10/2019	 	 	37,562	 
	9/26/2019	 	 	12,286	 
	9/26/2019	 	 	47,714	 
	2/25/2020	 	 	50,315	 
	1/11/2021	 	 	0	 
	1/11/2021	 	 	40,000	 
	1/11/2021	 	 	0	 





 


 











		1	This schedule reflects the vested options before the Termination
Date. The schedule will be updated promptly following signing to reflect the additional options that vest pursuant to the “Consideration”
Section of this Agreement upon the Termination Date.



 


			Pursuant to this Agreement, the vested options will be exercisable for three years following the
                                                                             Termination Date, but not beyond the applicable term of the option.